Firstly, while ERBB2 and CLU expression were found to be elevated in tumor tissues compared to non-tumor tissues, their expressions were lower in the high-risk group compared to the low-risk group, indicating an inconsistency between prognostic trend and expression pattern. Here, ERBB2 is linked to neoplasm.